Cargando…
The 'Harmonizing Optimal Strategy for Treatment of coronary artery stenosis - sAfety & effectiveneSS of drug-elUting stents & antiplatelet REgimen' (HOST-ASSURE) trial: study protocol for a randomized controlled trial
BACKGROUND: Second-generation drug-eluting stents (DES) have raised the bar of clinical performance. These stents are mostly made from cobalt chromium alloy. A newer generation DES has been developed from platinum chromium alloy, but clinical data regarding the efficacy and safety of the platinum ch...
Autores principales: | Park, Kyung Woo, Park, Byoung-Eun, Kang, Si-Hyuck, Park, Jin-Joo, Lee, Seung-Pyo, Cha, Kwang Soo, Rhew, Jay Young, Jeon, Hui-Kyoung, Shin, Eun Seok, Oh, Ju Hyeon, Jeong, Myung-Ho, Kim, Sanghyun, Hwang, Kyung-Kuk, Yoon, Jung-Han, Lee, Sung Yun, Park, Tae-Ho, Moon, Keon Woong, Kwon, Hyuck-Moon, Chae, In-Ho, Kim, Hyo-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342216/ https://www.ncbi.nlm.nih.gov/pubmed/22463698 http://dx.doi.org/10.1186/1745-6215-13-29 |
Ejemplares similares
-
Effectiveness and Safety of Biolimus A9™-Eluting stEnt in Patients with AcUTe Coronary sYndrome; A Multicenter, Observational Study (BEAUTY Study)
por: Park, Keun-Ho, et al.
Publicado: (2018) -
Efficacy and safety of antiplatelet-combination therapy after drug-eluting stent implantation
por: Cho, Yun-Kyeong, et al.
Publicado: (2014) -
Safety of 3‐Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus‐Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART‐CHOICE Trial
por: Yun, Kyeong Ho, et al.
Publicado: (2020) -
Efficacies of the new Paclitaxel-eluting Coroflex Please™ Stent in percutaneous coronary intervention; comparison of efficacy between Coroflex Please™ and Taxus™ (ECO-PLEASANT) trial: study rationale and design
por: Seo, Jae-Bin, et al.
Publicado: (2009) -
Triple Antiplatelet Therapy with Cilostazol and Favorable Early Clinical Outcomes after Acute Myocardial Infarction Compared to Dual Antiplatelet Therapy with Standard or Potent P2Y12 Inhibitors
por: Byun, Sungwook, et al.
Publicado: (2022)